版权说明 操作指南
首页 > 成果 > 详情

ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents

认领
导出
下载 Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Zu, Xu-Yu;Zhang, Qing-Hai;Liu, Jiang-Hua;Cao, Ren-Xian;Zhong, Jing;...
通讯作者:
Pizzorno, Giuseppe
作者机构:
[Zhong, Jing; Quan, Zhi-Hua; Zhang, Qing-Hai; Cao, Ren-Xian; Zu, Xu-Yu; Liu, Jiang-Hua] Univ S China, Affiliated Hosp 1, Clin Res Inst, Hengyang 421001, Hunan, Peoples R China.
[Pizzorno, Giuseppe] Desert Res Inst Summerlin, Human Hlth & Environm Program, Las Vegas, NV 89135 USA.
[Yi, Guang-Hui] Univ S China, Sch Med, Inst Cardiovasc Dis, Hengyang 421001, Hunan, Peoples R China.
[Pizzorno, Giuseppe] Desert Res Inst Summerlin, Human Hlth & Environm Program, 10530 Discovery Dr, Las Vegas, NV 89135 USA.
通讯机构:
[Pizzorno, Giuseppe] D
Desert Res Inst Summerlin, Human Hlth & Environm Program, 10530 Discovery Dr, Las Vegas, NV 89135 USA.
语种:
英文
关键词:
ACL inhibitors;ATP citrate lyase;Hydroxycitrate;Non-hydroxycitrate Citric Acid Analogues;Posttranslational regulation;Transcriptional regulation;cancer therapy;citrate;lipogenesis;small chemicals
期刊:
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY
ISSN:
1574-8928
年:
2012
卷:
7
期:
2
页码:
154-167
基金类别:
Hunan Provincial Natural Science Foundation of ChinaNatural Science Foundation of Hunan Province [11JJ4068]; Medical Scientific Research Foundation of Hunan Province, China [B2010-045]
机构署名:
本校为第一机构
院系归属:
医学院
摘要:
ATP citrate lyase (ACL or ACLY) is an extra-mitochondrial enzyme widely distributed in various human and animal tissues. ACL links glucose and lipid metabolism by catalyzing the formation of acetyl-CoA and oxaloacetate from citrate produced by glycolysis in the presence of ATP and CoA. ACL is aberrantly expressed in many immortalized cells and tumors, such as breast, liver, colon, lung and prostate cancers, and is correlated reversely with tumor stage and differentiation, serving as a negative prognostic marker. ACL is an upstream enzyme of the long chain fatty acid synthesis, providing acetyl...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com